home / stock / anix / anix news

ANIX News and Press, Anixa Biosciences Inc. From 07/24/19

Stock Information
Company Name: Anixa Biosciences Inc.
Stock Symbol: ANIX
Market: NASDAQ
Website: anixa.com
Menu
ANIX ANIX Quote ANIX Short ANIX News ANIX Articles ANIX Message Board
Get ANIX Alerts

News, Short Squeeze, Breakout and More Instantly...
ANIX - Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology

SAN JOSE, Calif. , July 24, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,36...
ANIX - Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins Cchek(TM) Prostate Cancer Study

SAN JOSE, Calif. , July 22, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that it is partnering with the VA Maryland Health Care System's Baltimore VA Medical Cent...

ANIX - AVRO, NUS, SCPL and SGEN among midday movers

Gainers:  Nautilus (NYSE: NLS ) +21% . Francesca's Holdings (NASDAQ: FRAN ) +20% . Anixa Biosciences (NASDAQ: ANIX ) +19% . AVROBIO (NASDAQ: AVRO ) +19% . Rekor Systems (REKR) +18% . Seattle Genetics (NASDAQ: SGEN ) +18% . Hill International (NYSE: HIL ) +18% . scPharmaceutical...

ANIX - Anixa Bio teams up with Cleveland Clinic to investigate breast cancer vaccine

Anixa Biosciences (NASDAQ: ANIX ) inks a strategic alliance and license agreement with Cleveland Clinic aimed at developing a vaccine against triple negative breast cancer (TNBC), its most aggressive and treatment-resistant form. More news on: Anixa Biosciences, Inc., Healthcare stocks n...
ANIX - Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology

SAN JOSE, Calif. , July 17, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that it has established a strategic alliance and license agreement with Cleveland Clinic ...

ANIX - Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells

SAN JOSE, Calif. , July 16, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced it will make available reprints of a recent study in the Journal of Experimental Medicine...

ANIX - Anixa Biosciences to Present at the CYTO 2019 - 34th Congress of the International Society for Advancement of Cytometry

SAN JOSE, Calif. , May 29, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will present updated data from its study utilizing Cchek™, its artificial intell...
ANIX - Anixa Biosciences to Present at the Sachs Associates 5th Annual Immuno-Oncology BD&L and Investment Forum

SAN JOSE, Calif. , May 21, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that it will be presenting at the Sachs Associates 5 th Annual Immuno-Oncology BD&L and In...

ANIX - Anixa Biosciences Announces Completion of Cchek(TM) Analytical Verification at CLIA Laboratory

SAN JOSE, Calif. , May 13, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that its Cchek™ Prostate Cancer Confirmation (Cchek™ PCC) tes...

ANIX - Anixa Biosciences to Present at B. Riley FBR Institutional Investor Conference

SAN JOSE, Calif. , May 2, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body's immune system to fight cancer, today announced that it will be presenting at the 20 th Annual B. Riley FBR Institutional Investor Conference t...
Previous 10 Next 10